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Human killer cell immunoglobulin-like recep-
tors (KIRs) and murine lectin-like Ly49 re-
ceptors perform orthologous functions despite 
their striking diff   erence in protein structure 
and evolutionary origin (1, 2). As receptors for 
polymorphic MHC class I, KIR and Ly49 reg-
ulate NK cell tolerance and response (3). Inde-
pendently, the human KIR and murine Ly49 
gene families acquired some remarkably similar 
features, including variegated expression (4–6), 
signaling pathways (7), and haplotypes vary-
ing in gene content, allelic polymorphism, and 
signaling potential (8). Two groups of human 
KIR haplotypes are defi  ned (9, 10). Group A 
haplotypes have a fi  xed organization of seven 
genes, most with inhibitory potential; the group 
B haplotypes have a variable number of KIR 
genes, many with activating function. Clinical 
studies have correlated KIR gene content with 
infection, cancer, autoimmunity, pregnancy 
syndromes, and transplant outcome (11–16). 
Most of these associations are with activating 
KIR genes and group B haplotypes and favor 
success in reproduction and fi  ghting infection, 
but also in increased autoimmunity (3).
Although the inhibitory receptors for 
HLA-A (KIR3DL2), -B (3DL1), -C (2DL1, 
2 and 3), and the activating receptor for HLA-G 
(2DL4) are well studied (17–20), the functional 
eff  ects of their polymorphism remain largely 
unexplored. Ligands for the inhibitory 2DL5 
and the activating 2DS1, 2, 3, 4, 5, and 3DS1 
are unknown or uncertain. The NK cell reper-
toire depends on both KIR and HLA polymor-
phisms. Thus, KIR and HLA identical siblings 
have similar NK cell repertoires, whereas sib-
lings diff  ering at KIR or HLA exhibit a range 
of phenotype diff  erence (21). Uncertain from 
that analysis was whether HLA serves to make 
positive or negative selection. Complicating 
further investigation of KIR–HLA   interactions 
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has been the extent of their diversity. Population compari-
sons revealed ethnic diff  erences in the ratio of group A and B 
KIR haplotypes. In East Asian populations, the simpler group 
A haplotypes dominate, suggesting their KIR diversity might 
be more simple and experimentally more tractable than for 
Caucasians (22–24). Here, in-depth analysis of KIR geno-
type, phenotype, and function in the Japanese shows this hy-
pothesis to be true.
RESULTS
KIR gene content was determined for 132 unrelated Japanese 
donors. 11 KIR genotypes were distinguished (Fig. 1). [ID]FIG1[/ID] With 
a frequency of 80%, the group A haplotypes dominated. 
These results extend the preliminary study of 41 donors (22), 
giving confi  dence that the results obtained here well repre-
sent the KIR system of the Japanese population. Full-length 
cDNA from KIR expressed in peripheral blood was cloned 
and sequenced from 53 panel members. In selecting donors 
and the KIR to be sequenced from each donor, we sampled 
the full range of the panel’s genotypes (Fig. 1) and pheno-
types (Fig. 2); 18–25% of donors positive for each KIR were 
analyzed by cDNA cloning and sequencing, predicting de-
tection of all alleles with >6% frequency. [ID]FIG2[/ID]
Sequencing >1,100 clones identifi  ed 41 distinct KIR, of 
which 14 were novel (Fig. 1). Polymorphism concentrated 
on the group A haplotype genes, particularly those in the 
telomeric part of the locus. Genes that distinguish group B 
haplotypes (2DS1, 2, 3, 5, 3DS1, 2DL2, 2DL5) were rep-
resented by only one or two variants. Methods that distin-
guish the KIR alleles were devised and used to type 116 panel 
 members. Each polymorphic KIR gene has a dominant allele, 
with a frequency of 45–89% compared with 4–17% for the 
next most common allele (Fig. 1). For 2DL4 and 2DS4, non-
functional alleles caused by frame-shifting deletions accounted 
for 19 and 38% of the total alleles, respectively. In contrast, 
the common nonfunctional 3DL1*004 allele of Caucasians 
(17%) is absent from the Japanese (Fig. S1, available at http://
www.jem.org/cgi/content/full/jem.20051884/DC1).
Polymorphism modulates the level and frequency 
of KIR3D expression
The variation in KIR phenotype of NK cells from 104 donors 
was assessed by fl   ow cytometry using four anti-KIR anti-
bodies and correlated with genotype (Fig. 2). The fi  ve 
KIR3DL1 allotypes had diff  erent levels of DX9 binding. The 
levels ranged over an order of magnitude, with the hierarchy 
3DL1*005<*007<*001<*020<*01502 (Fig. 3 A, left).[ID]FIG3[ /ID] 
Comparison of diff   erent anti-KIR3DL1 antibodies and of 
DX9 binding kinetics showed the allotypic diff  erences are the 
result of the abundance of cell surface 3DL1, not variable 
affi   nity for DX9 (Fig. S2, available at http://www.jem.org/
cgi/content/full/jem.20051884/DC1, and  <CIT>references 25–
27</CIT>). Also correlating with binding level was the frequency of 
cellular expression so that high-binding allotypes (*001, *020, 
and *01502) were expressed by a larger proportion of NK cells 
than low-binding allotypes (*005 and *007) (Fig. 3 A, right). 
The frequency of NK cell expression also increased with gene 
dose: individuals having two low or high expressing 3DL1 
Figure 1.  KIR locus variability in the Japanese population. (top) 
KIR genotype and frequency in a panel of 132 donors. A shaded box indi-
cates the presence of a gene; an unshaded box represents its absence. 
The deleted form of the 3DP1 pseudogene is indicated by “∆,” the full-
length form is indicated by “F.” The genotype frequencies are compared 
with previous analysis of 41 donors ( <CIT>reference 22 </CIT>). (bottom) Allele fre-
quencies for the polymorphic genes are listed in order of decreasing 
frequency. Full-length (10A) and deleted (9A) forms of 2DL4 are desig-
nated “F” and “D,” respectively (this is also the case for full-length and 
deleted forms of 2DS4). KIR2DL2 and 2DL3 are considered alleles, as are 
3DL1 and 3DS1. Alleles with novel changes in the coding region are 
  denoted “#.” “◊” denotes alleles defi  ned by a novel change only in the 
untranslated region and are given preexisting allele names based on 
the coding region.JEM VOL. 203, March 20, 2006  635
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  allotypes had mean frequencies of expression that were 1.7- 
and 1.9-fold greater, respectively, than individuals having one.
Polymorphism also aff  ected the frequency and level of 
3DL2 expression. Signifi  cant  diff   erences were observed 
  between 3DL2*008 (high-binding) and 3DL2*007 and 
3DL2*00902 (low-binding). Compared with other allotypes, 
3DL2*008 and 3DL2*002 had a higher frequency of NK cell 
expression (Fig. 3 B). Like 3DL1, a gene dose eff  ect was seen 
from comparison of individuals with one or two high-
  expressing allotypes (Fig. 3 C). Lower binding levels and 
smaller diff  erences between allotypes limited 3DL2 analysis 
compared with 3DL1. KIR3DL2 heterozygotes did not give 
the readily interpreted bimodal distributions seen for 3DL1. 
Furthermore, there were nine 3DL2 allotypes, compared 
with fi  ve for 3DL1, which increased the number of hetero-
zygous combinations and reduced the frequency of the more 
readily analyzed homozygotes.
For 2DL1/S1, the frequency of NK cells binding EB6 
and their binding level both increased with the number 
of genes encoding KIR that bind the antibody (Fig. 3 C). 
  Although no eff  ects correlating with 2DL1 polymorphism 
were observed, the panel’s high 2DL1*00302 frequency sug-
gests that its high binding could have obscured the eff  ects of 
low-binding allotypes in heterozygotes. Regarding the anti-
2DL2/3+2DS2 antibody (DX27), panel members were 
either homozygous for 2DL3 or had one copy each of 2DL2, 
2DL3, and 2DS2. Donors with the latter genotype had a 
similar frequency of antibody-binding NK cells, but a sub-
stantially increased level of binding (Fig. 3 C).
Cognate HLA class I increases the frequency of NK cells 
expressing inhibitory KIR
HLA-A, -B, -C types for the panel were determined at high 
resolution (Fig. S3 A, available at http://www.jem.org/cgi/
content/full/jem.20051884/DC1). Both the alleles and their 
frequencies were consistent with previous studies (28, 29). 
Hardy-Weinberg equilibrium was observed for KIR and 
HLA (Fig. S3 B). Distinguishing Japanese from Caucasians 
are the frequencies of HLA-C ligands for KIR2DL. In Cau-
casians, 66% of HLA-C allotypes have C1 (the 2DL2/3 
  ligand) and 34% have C2 (the KIR2DL1 ligand); whereas in 
Japanese, 92% have C1 and 8% have C2. Thus, almost all 
Japanese use C1 as a self-ligand for inhibitory KIR, whereas 
a small minority use C2. The frequency of HLA-A3/11 lig-
ands for 3DL2 is also lower in Japanese (8%) than in Cauca-
sians (22%), whereas they have identical frequency for HLA-
Bw4, the 3DL1 ligand (36%).
KIR phenotypes were compared for donors who have or 
lack a cognate HLA class I ligand for particular KIR. In several 
combinations, presence of cognate ligand increased the fre-
quency of NK cells expressing the KIR (Fig. 4 A), while de-
creasing the amount of KIR-specifi  c antibody that is bound 
(Fig. 4 B). [ID]FIG4[/ID] In 2DL1 homozygotes, the presence of cognate C2 
almost doubled the frequency of 2DL1+ NK cells while 
Figure 2.  Variability of KIR cell surface phenotype in the Japanese 
population. Each panel shows fl  ow cytometry data obtained from NK cells 
stained with a different anti-KIR monoclonal antibody: EB6, anti-2DL1 and 
2DS1; DX27, anti-2DL2/3 and 2DS2; DX9, anti-3DL1; and DX31, anti-3DL2. 
The percentage of NK cells that binds antibody (x axis) is plotted against the 
mean fl  uorescence intensity (mfi  ) (y axis), a measure of the amount of 
antibody bound. Each donor is represented by one data point in each of the 
four two-dimensional plots. The key gives allele-level genotypes that were 
subsequently assigned to each person. For donors giving bimodal patterns 
of DX9 binding, the high and low peaks are represented separately.636  EFFECTS OF HLA AND KIR POLYMORPHISMS ON NK CELL REPERTOIRE AND EFFECTOR FUNCTION | Yawata et al.
  reducing the level of anti-2DL1 binding by 26%. Although the 
panel’s high C1 frequency precluded comparable analysis of 
2DL2/3, the two donors who lacked C1 showed decreased 
frequency of 2DL2/3-expressing cells and reduced levels of 
antibody binding (Fig. S4, available at http://www.jem.org/
cgi/content/full/jem.20051884/DC1). C1 homozygotes had 
decreased binding of anti-2DL2/3 to NK cells compared with 
C1/C2 heterozygotes. Presence of Bw4 signifi  cantly increased 
the frequency of cells expressing 3DL1 for donors having 
two high-binding 3DL1 allotypes and decreased the level of 
anti-KIR3DL1 bound for donors having one high-binding 
3DL1 allotype (Fig. 4, A and B). For donors having one high-
binding 3DL1 allotype, paired with a low binding allotype or 
3DS1, there was little eff  ect on expression frequency, as also seen 
for donors having two low-binding allotypes (Fig. 4 C, top).
Cognate HLA class I decreases the frequency of NK cells 
expressing other inhibitory KIR
For donors with two high-binding 3DL1 allotypes, the in-
crease in frequency of 3DL1+ NK cells is greater in Bw4 
Figure 3.  Allelic polymorphisms of KIR3DL genes determine dif-
ferent levels of cell surface expression. (A) The central panel shows 
fl  ow cytometric analysis of NK cells stained with the DX9 antibody. The 
x and y axes are the same as in Fig. 2. Each large data point represents a 
single person; however, the high and low peaks in donors with bimodal 
DX9 binding patterns are each represented independently with small 
data points. 3DL1/3DS1 heterozygotes are represented as one small 
data point. The 3DL1 genotypes are represented by different symbols; 
■: 3DL1*001 × 1, ■: *001+*01502, ∆: *01502+*020, □: *005 × 1, 
□: *005 × 2, ▲: *007 × 1, ▲: *007 × 2, ●: *01502 × 1, ●: *01502 × 2, 
○: *020 × 1, ○: *020 × 2. The staining as a result of the “low-binding allo-
types” (3DL1*005 and *007) is distinguished from that of the “high-bind-
ing allotypes” (3DL1*001, *01502, and *020) by the gates. The left panel is 
a one-dimensional plot of mfi   showing how each of the fi  ve 3DL1 allo-
types corresponds to a different range and mean value of DX9 binding. 
The right panel is a one-dimensional plot of percentage of NK cells bind-
ing DX9 in which the panel members were divided into four groups ac-
cording to 3DL1 genotype: one low-binding allotype, two low-binding 
allotypes, one high-binding allotype, and two high-binding allotypes. 
The frequency of NK cells expressing 3DL1 increases with gene dose. 
(B) Correlations between fl  ow cytometric analysis (%NK cells and mfi  ) 
with DX31 and the different 3DL2 allotypes. Pairwise comparisons were 
made between phenotypes with and without each 3DL2 allotype in “1),” 
or with and without the allotype group comprising 3DL2*002 and *008 
in “2).” (C) The effects of gene dose on %NK cells and mfi   observed with 
EB6, DX31, and DX27. Pairwise comparisons were made in phenotypes 
between the two donor groups that differed in gene content as 
indicated from “1)” to “4).” One copy of a gene is shown by x1, two 
  copies are shown by x2. *, P < 0.05; **, P < 0.01; ***, P < 0.005; 
and *****, P < 0.0005.JEM VOL. 203, March 20, 2006  637
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  heterozygotes than in homozygotes (Fig. 4 C, top). The ef-
fect of cognate Bw4 to increase the frequency of 3DL1+ cells 
was also depressed by the presence of additional cognate 
HLA–KIR interactions, and the eff  ects were additive. Thus, 
for individuals who had all four inhibitory ligands (C1, C2, 
Bw4, and A3/11), the frequencies of 3DL1+ cells are compa-
rable to those in individuals lacking Bw4 (Fig. 4 C, top). 
  Although similar trends were seen for individuals having one 
Figure 4.  The infl  uence of cognate HLA class I on KIR expression 
by NK cells. (A) Infl  uence of ligand on the frequency of cognate KIR 
expression. (left) For individuals who have two copies of 2DL1 and no 
2DS1, the percent of NK cells expressing 2DL1 is compared between those 
who lack the C2 ligand (C1/1 genotype) and those who have one copy of 
it (C1/2 genotype). (right) For individuals who have two high-expressing 
3DL1 allotypes, the percent of NK cells expressing 3DL1 is compared 
  between those who lack the Bw4 ligand (Bw6/6 genotype) and those who 
have one copy of it (Bw4/6 genotype). (B) Infl  uence of ligand on the anti-
body binding to cognate KIR. (left) For individuals who have two copies 
of 2DL1 and no 2DS1, the mean binding of anti-2DL1 to 2DL1-expressing 
NK cells is compared between those who have no C2 ligand, one C2 
  ligand, and two C2 ligands (C2/2 genotype). (right) For individuals who 
have one high-expressing 3DL1 allotype, the mean binding of anti-3DL1 
to NK cells expressing 3DL1 is compared between those who have no 
Bw4 ligand, one Bw4 ligand, and two Bw4 ligands. (C) Infl  uence of other 
ligand–receptor pairs on KIR expression. (top four panels) In each panel, 
the frequency of cells expressing 3DL1 is compared in four groups 
of individuals: those who lack Bw4 and are homozygous for C1 
(Bw6/6+C1/1); those who are heterozygous for Bw4 and homozygous for 
C1 (Bw4/6+C1/1); those who are homozygous for Bw4 and C1 (Bw4/
4+C1/1); and those who are either heterozygous or homozygous for Bw4 
and have two or more other self-ligands for inhibitory KIR (Bw4 + ≥2 
ligands). Each of the four panels corresponds to individuals with different 
3DL1 genotypes: two high-expressing allotypes (far left), one high and 
one low-expressing allotype (center, left), one high-expressing allotype 
and 3DS1 (center, right), and two low-expressing allotypes (far right). 
Black triangles below each panel indicate increasing number of KIR 
  ligands. (bottom) In each panel, the frequency of cells expressing 2DL2/3 
and 2DS2 is compared in three groups of individuals: those who are 
homozygous for C1 (C1/1);, those who are homozygous for C1 and have 
one additional self-ligand for inhibitory KIR (C1/1 + 1 ligand); and those 
who are either homozygous for C1 and have two or more additional self-
  ligands for inhibitory KIR or are heterozygous for C1/C2 and have one or 
more additional self-ligands for inhibitory KIR (C1 + ≥2 ligands). The 
four panels correspond to the same groups based upon KIR3DL1/S1 
  genotype as the top panels. *, P < 0.05; **, P < 0.01; ***, P < 0.005; and 
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high-binding 3DL1 allotype, they did not reach statistical 
  signifi  cance. A similar eff  ect of other cognate HLA–KIR 
  interactions was also seen from analysis of the frequency of 
NK cells expressing 2DL2/3 (Fig. 4 C, bottom).
Allelic polymorphism modulates the inhibitory 
function of KIR3DL1
Approximately one third of the Japanese population has C1-
2DL3 as the only functional inhibitory KIR–HLA class I 
interaction, while one half of the population can also use the 
Bw4–3DL1 interaction. Although 2DL3 has little polymor-
phism in the Japanese, 3DL1 variation is substantial (Fig. 1). 
Consequently, the Bw4–3DL1 interaction is a potentially 
important source of functional NK cell diversifi  cation in the 
Japanese population. To address this question, the functions 
of the fi  ve 3DL1 allotypes present in the Japanese panel 
were compared.
PBMCs from 13 donors, each having a high- and low-
binding 3DL1 allotype, were challenged with class I–  defi  cient 
721.221 cells and with 221 cells transfected with HLA-
B*5801, a 3DL1 ligand. In response to 221 cells, 3DL1+ NK 
cells produced IFN-γ as detected by intracellular staining. 
A diminished response was made to 221- B*5801, the in-
hibition varying 40–90% between the fi  ve 3DL1 allotypes 
(Fig. 5, top). [ID]FIG5[/ID] The hierarchy for increasing inhibition was 
3DL1*007<*020<*01502<*005<*001. That 3DL1 poly  -
mor  phism modulates a major NK cell eff  ector function demon-
strates its functional importance. Of note, the two allotypes 
giving strongest inhibition are those expressed at inter-
mediate (3DL1*001) and lowest levels (3DL1*005).
Further modulating each 3DL1 allotype’s capacity to in-
fl  uence the NK cell response is its expression frequency in 
the NK cell population. Consequently, the impact of an allo-
type such as 3DL1*005 could be restricted to a relatively 
small number of cells. By taking both factors (the frequencies 
of expression and inhibition) into account, we estimated the 
frequency of NK cells in peripheral blood that are inhibitable 
by B*5801 (Fig. 5, bottom). The diff  erence between this 
  hierarchy (3DL1*007<*005<*020<*01502<*001) and 
that in Fig. 5′s top half is the position of 3DL1*005, which 
shifts from the second strongest to second weakest allotype.
Positive and balancing selection of KIR
70 allele-level KIR genotypes were distinguished in the panel. 
From these genotypes and the sequences of prototypical 
group A (GenBank accession no.  <GENBANK>AC011501 </GENBANK>) and group B 
(GenBank accession no. <GENBANK>AY320039 </GENBANK>) haplotypes, the struc-
tures of Japanese KIR haplotypes were inferred by two inde-
pendent methods. The 20 most frequent haplotypes were 
identically ranked (Fig. 6 A). [ID]FIG6[/ID] Each was identifi  ed in two or 
more donors and, collectively, they account for 83.4% of the 
panel’s haplotypes. In both gene content and allelic polymor-
phism, the telomeric part of Japanese KIR haplotypes is more 
variable than the centromeric part. Together, the 12 deduced 
A haplotypes comprise 67.7% of total haplotypes compared 
with 15.7% for the 8 deduced B haplotypes. One A haplo-
type is markedly more common (35.7%) than any other hap-
lotype (<9%) and, for each of its component KIR genes, this 
haplotype has the dominant allele.
Application of the Ewens-Watterson test (30, 31) to the 
polymorphic KIR genes of the group A haplotypes shows 
that centromeric genes specifying HLA-C receptors (2DL1 
and 3) have been subject to positive directional selection 
(Fig. 6 B), consistent with the high frequencies of the domi-
nant alleles at these genes (Fig. 1). In contrast, the telomeric 
2DL4, 3DL1, 2DS4, and 3DL2 genes, including those en-
coding HLA-A, -B, and -G receptors, appear subject to bal-
ancing selection, consistent with their wider range of allele 
frequencies. Tajima’s D statistic (32) was also used to assess 
the mode and strength of selective pressure on polymorphic 
sites in group A haplotypes, using composite 7-kb haplotypes 
constructed from the coding sequences of KIR alleles in 
their order on the haplotype (Fig. 6 C, within the panel). 
Aside from confi  rming directional selection on the 2DL1 and 
3 genes, this analysis revealed a strong signature for balancing 
Figure 5.  KIR3DL1 allotypes have different inhibitory capacity. 
PBMCs from heterozygous donors expressing one high- and one low-
expressing 3DL1 allotype were cultured with class I–defi  cient 721.221 
cells or 221 cells transfected with HLA-B*5801, a 3DL1 ligand. The produc-
tion of IFN-γ by CD3−3DL1+ cells (3DL1+NK cells) was determined by 
fl  ow cytometry. Cells expressing the high and the low expressing allotypes 
formed distinct distributions and were analyzed separately. For each 3DL1 
allotype, the number of cells producing IFN-γ in response to 221 and 
221-B*5801 was compared and the inhibition mediated by B*5801 was 
calculated as the percentage of CD3−3DL1+ NK cells (top) or total NK 
cells (bottom), as defi  ned by CD3−CD56+ PBMC in the KIR phenotype 
analysis of the donor panel. The number of donors tested for each allo-
type is shown in parenthesis below the allotype name. Signifi  cance values 
for pairwise comparisons are: *01502/*005: P < 0.02; *01502/*007: 
P < 0.005; *005/*007: P < 0.003; *020/*005: P < 0.03. Error bars represent 
the standard deviation of the results obtained with the number of donors 
shown (bottom).JEM VOL. 203, March 20, 2006  639
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Figure 6.  KIR haplotypes have been subject to balancing selection 
and positive directional selection. (A) Deduced allele-level KIR haplo-
types. Shown are the 20 most common haplotypes, their frequencies, and 
their assignment to group A or B. These haplotypes were all identifi  ed by 
independent analytical methods: the EM-algorithm and the Bayesian 
phasing method. Independent analysis of three families confi  rmed the 
segregation of haplotypes 1, 2, 3, 5, 7, 13, and 15 (not depicted). (B) The 
Ewens-Watterson homozygosity statistic (F) was used to assess the de-
parture from neutrality of the KIR allele frequencies in 116 Japanese do-
nors. The thick line shows the neutral expectation. F values that are higher 
than the neutral expectation indicate purifying or directional selection; 
those that are lower than neutral expectation indicate balancing selec-
tion. The thin line shows the limit at maximum balancing selection. The 
2DS4, 3DL1, 2DL4, and 3DL2 genes from the telomeric part of the KIR 
locus appear subject to balancing selection (**, P < 0.01 and #, P < 0.1). 
2DL1 and 2DL3 genes in the centromeric part of the KIR locus show a 
trend toward purifying or directional selection. (C) Tajima’s D statistic was 
applied to a composite of 182 group A coding-region haplotypes using a 
sliding window. The positions of the individual KIR in the composite are 
shown along the bottom of the panel. Positive values are indicative of 
balancing selection, negative values of purifying or directional selection. 
*, P < 0.05; ****, P < 0.001; and #, P < 0.1. Beneath the panel the results 
are shown for the Ewens-Watterson test on the centromeric and telo-
meric parts of the 182 group A haplotypes. Signifi  cance was assessed by 
Watterson’s exact test. For both parts, the observed homozygosity was 
higher than expected. (D) The 182 group A haplotypes are all variants of 
fi  ve basic forms, which can be defi  ned by the fi  ve KIR3DL1 alleles. For 
each of these fi  ve subgroups, the haplotype homozygosity is shown. The 
subgroups are as follows: ●: 3DL1*01502, ▲: 3DL1*005, ∆: 3DL1*007, 
□: 3DL1*001, ○: 3DL1*020. For each haplotype subgroup, there is a 
central region of high LD encompassing the 2DL4, 3DL1, and 2DS4 genes, 
which is fl  anked by regionsof reduced LD.640  EFFECTS OF HLA AND KIR POLYMORPHISMS ON NK CELL REPERTOIRE AND EFFECTOR FUNCTION | Yawata et al.
selection in the telomeric region, one focusing on the ligand-
binding domains of 2DL4, 3DL1, and 2DS4 and the signaling 
domain of 2DL4.
Linkage disequilibrium (LD) can indicate positive selec-
tion (33). Haplotype homozygosity revealed relatively high 
LD throughout the Japanese group A haplotypes; in particu-
lar, from 2DL4 through 3DL1 to 2DS4 (Fig. S5, available at 
http://www.jem.org/cgi/content/full/jem.20051884/DC1). 
Within this core region, the fi  ve 3DL1 alleles are linked 
with diff   erent combinations of alleles for the other two 
genes. These various cores are further diversifi  ed by com-
bination with diff  erent 3DL2 alleles, the number depend-
ing on the core (Fig. 6 D). For example, 3DL1*005 pairs 
with four 3DL2 alleles, whereas the haplotype containing 
the dominant 3DL1*01502 allele is almost homogeneous, 
which is strong evidence for its positive selection, a selec-
tive sweep. As an independent assessment, the Ewens-
Watterson homozygosity statistic was calculated for the centro     -
meric and telomeric parts of the group A haplotypes and tested 
for departure from neutrality. In both parts of the KIR locus, 
signatures of positive selection were detected (Fig. 6 C, below 
the panel).
These analyses show that positive selection drove one 
group A haplotype to high frequency, such that its compo-
nent alleles are now the dominant alleles of the polymorphic 
KIR genes. Positive selection also homogenized the centro-
meric part of the KIR locus. In contrast, balancing selection 
on telomeric KIR has maintained a variety of other haplo-
types and their component alleles at intermediate frequencies. 
Because of these contrasting selections, a majority of Japanese 
( 75%) have the same centromeric KIR genes, including the 
HLA-C–specifi  c KIR2DL, but diff  er in the telomeric genes, 
including the HLA-A– and -B–specifi  c KIR3D.
In addition to the 20 haplotypes shown in Fig. 6 A, 24 
rarer haplotypes were deduced by assuming patterns of LD 
defi  ned previously in other populations (34). Of the 44 haplo-
types, 24 were group A and 20 group B. 30 of the 44 haplo-
types share some alleles with the most common haplotype 
(no. 1) (Fig. S6, available at http://www.jem.org/cgi/content/
full/jem.20051884/DC1). As well as a high frequency group A 
haplotype, the Japanese population has an abundance of 
low frequency A and B haplotypes with centromeric and 
telomeric motifs distinct from those present in the common 
haplotypes. These provide a pool of diverse functional potential 
for natural selection to operate on in the future.
Non-random associations of KIR–HLA in females
Systematic analysis revealed combinations of KIR and HLA 
genes in the donor panel at non-random frequencies. Strati-
fi  cation by sex showed that the eff  ect was confi  ned to females 
(Fig. 7). [ID]FIG7[/ID] Deleted, nonfunctional forms of 2DL4 (35) prefer-
entially associated with C2, whereas homozygosity for func-
tional, full-length 2DL4 correlated negatively with C2. 
3DL1*005 preferentially associated with Bw4, a combination 
also favoring inhibitory interaction. Although C2 and Bw4 
are in strong LD in Caucasians, that is not so for Japanese, for 
whom only 40% of C2-carrying haplotypes also have HLA-Bw4 
(36). Also, only 50% of donors carrying C2 have Bw4 (8 out 
of 16), a neutral distribution confi  rming the independence 
of C2 and Bw4 in the panel. Association with Bw4 is thus 
an independently associated factor and not a consequence of 
LD with C2. Weaker trends were HLA-C2 with 3DL1*005 
Figure 7.  Non-random KIR-HLA combinations in females. The ob-
served frequencies of KIR-HLA combinations in the Japanese panel were 
compared with the frequencies predicted by random combination. This 
revealed a small number of deviations, which were then found to be 
  present in females (top), but not males (bottom). Combinations with 
strong over-representation are shown in bold. As well as the p-value 
  obtained from the chi-square test, relative risk (rr) was also calculated as 
a measure of deviation and is shown with 95% confi  dence intervals (ci).JEM VOL. 203, March 20, 2006  641
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or  *001, the most potent inhibitors (Fig. 5), whereas 
3DL1*01502, the dominant allotype and less potent inhibi-
tor, correlated negatively with C2.
Six core haplotypes are defi  ned by the fi  ve 3DL1 alleles 
and 3DS1 (Fig. 8). [ID]FIG8[/ID] The cores defi  ned by 3DL1*005 and 
*001 both encode deleted, nonfunctional forms of 2DL4 and 
2DS4. Group A haplotypes with these cores lack activating 
KIR and have a strong inhibitory Bw4 receptor as well as in-
hibitory receptors for C1 and C2. Consequently, the over-
represented combination of 3DL1*005, nonfunctional 2DL4, 
Bw4 homozygosity, and C2 (usually accompanied by C1) is 
one that suggests some selection for strong inhibitory KIR–
HLA interactions. Conversely, the underrepresented combi-
nations of functional forms of 2DL4 with C2 suggest selection 
for less inhibition and more activation.
D  I  S  C  U  S  S  I  O  N 
Selection of NK cell KIR repertoire by cognate HLA 
class I ligands
In mouse models, acquisition of inhibitory Ly49 receptors by 
NK cells is informed by interactions with cognate MHC class I 
ligands expressed on bone marrow stromal cells (37). The 
common observation is that cognate ligand, usually a trans-
gene product, reduces the frequency of receptor-expressing 
cells. For humans, we fi  nd both increase and decrease in the 
frequency of receptor expression, which depends on the 
number of cognate KIR–HLA pairs contributing to NK cell 
self-tolerance. When acting alone, the cognate ligand in-
creases the frequency of the KIR’s expression, but the eff  ect 
varies with receptor and ligand gene dose. Such increase 
is consistent with previous observation that NK cell self-
  tolerance is mediated by inhibitory HLA class I receptors (6). 
In the presence of other ligand–receptor pairs, the expression 
frequency for each receptor is reduced from that achieved 
when it acts alone, and to an extent inversely correlated with 
the number of functional ligand–receptor pairs.
For mice, it has been proposed that sequential or stochas-
tic expression of inhibitory self-reactive receptors occurs un-
til cumulative inhibition reaches some threshold, whereupon 
further receptor acquisition stops (38–40). Our results fi  t with 
this type of model. That the cognate ligand has not been ob-
served to elevate receptor expression frequency in mice could 
refl  ect a diff  erence in the mechanism between the two spe-
cies or in the mode of analysis. For example, the presence in 
mice of multiple Ly49 products with overlapping ligand 
specifi  city could have obscured the positive eff  ect, as we ob-
served for humans with multiple KIR–HLA pairs.
KIR polymorphism modulates NK cell effector function
For  33% of the Japanese population, C1 is the only self-
  ligand for inhibitory KIR. Because the Japanese are practically 
monomorphic for KIR2D and polymorphic for KIR3DL1, 
they provided a good context in which to investigate the func-
tion of 3DL1 polymorphism. The fi  ve 3DL1 allotypes present 
in the Japanese diff  er in their capacity to inhibit NK cell func-
tion; they also diff  er in repertoire, which is the frequency and 
level of cell surface expression. Much evidence shows that 
DX9 binding measures the amount of cell surface KIR3DL1 
(Fig. S10 and <CIT>references 25–27 </CIT>), so the allotypic diff  erences 
observed are not the result of varying affi   nity for DX9.
The allotypic diff  erences in the frequency and level of 
KIR3DL1 expression are distinguished from those caused by 
cognate ligand and represent a ligand-independent infl  uence 
of 3DL1 polymorphism on the primary NK cell repertoire. 
The eff  ects of cognate 3DL1–Bw4 interactions are also mod-
ulated by KIR3DL1 polymorphism. Notably, the increase in 
frequency induced by the cognate ligand is greater for high 
than for low-expressing KIR3DL1 allotypes. The overall 
trend is for inhibitory capacity to increase with the level and 
frequency of 3DL1 expression, an exception being 3DL1*005, 
which combines low frequency and level of expression with 
strong inhibitory function.
KIR diversity is subject to positive and balancing selection
An outstanding question is whether the haplotypic diversity 
and allelic polymorphism of KIR genes arose from functional 
selection or neutral change. From functional assay and statistical 
analysis, we provide evidence that balancing selection main-
tains a pool of alleles and haplotypes with distinguishable func-
tions upon which positive selection can act. In the Japanese, 
Figure 8.  Non-random KIR-HLA associations involve highly inhibi-
tory KIR haplotypes. Although the centromeric part of the KIR locus 
lacks variability in the Japanese, the “core” region encompassing the 2DL4, 
3DL1, and 2DS4 genes has six distinctive motifs (designated by Roman 
numerals I–VI) at signifi  cant frequency, each having a different 3DL1 
allele or 3DS1. For 2DL4 and 2DS4, the full-length functional forms are 
denoted by “F” and the deleted, nonfunctional forms are indicated by “D.” 
Under “Non-random associations,” the overrepresented combinations of 
KIR with HLA described in Fig. 7 are indicated by “+,” the underrepre-
sented combinations are indicated by “−.” The overrepresented combina-
tions involve core haplotypes IV and VI that have no activating receptor 
and the most inhibitory 3DL1 allotypes. nd, not detected.642  EFFECTS OF HLA AND KIR POLYMORPHISMS ON NK CELL REPERTOIRE AND EFFECTOR FUNCTION | Yawata et al.
one group A KIR haplotype has risen to unusually high fre-
quency, a selection that may have been targeted to the cen-
tromeric  KIR genes, because the 2DL1*00302 and 
2DL3*001 alleles of the selected haplotype are at frequencies 
approaching 90%. In contrast, in the telomeric parts of the 
locus, the balancing selection retained diversity as exempli-
fi  ed by the even frequency of other group A and group B 
haplotype motifs and the distribution of the six core group 
A haplotype structures (Fig. 8). In these regions, the selected 
haplotype encodes functional KIR2DL4 and KIR2DS4 forms 
and a KIR3DL1 allotype giving moderate inhibition. Within 
the set of Japanese A haplotypes, it is one that combines a full 
set of functional genes and good potential for both inhibition 
and activation. Because of this haplotype, the frequency of 
functional 2DL4 and 2DS4 alleles in the Japanese is much 
higher than in Caucasians (35, 41). One possible cause of the 
selective sweep is an epidemic of infectious disease where the 
selected haplotype enhanced the chance of surviving infec-
tion. Alternatively, women carrying this less inhibitory, more 
activating form of A haplotype could have above average re-
productive success, as might be suggested from the results of 
Hiby et al. (15).
Evidence for selection of KIR–HLA combinations 
in female genotypes
An unexpected and thought-provoking discovery is the over- 
and underrepresentation of certain KIR–HLA class I combi-
nations in Japanese females. Because KIR and HLA are on 
diff   erent chromosomes, the overrepresented combinations 
must confer some selective advantage, whereas the underrep-
resented combinations are disadvantageous. As only NK cells 
and T cells express KIR, the selective mechanism likely in-
volves one or both of these cell types. Candidate mechanisms 
can be distinguished according to when they might act: be-
fore conception, during fetal life, or after birth.
Acting before conception and biasing progeny genotype 
is mate choice. Extensive literature points to MHC polymor-
phism infl  uencing the choice of sexual partners (42–44), and 
it is plausible that this biology could extend to combinations 
of KIR and HLA polymorphisms. For example, preferential 
choice of Bw4+ partners by Bw4+, 3DL1*005+ individuals 
would lead to enrichment in the next generations of geno-
types combining Bw4 homozygosity with 3DL1*005. For 
mate choice, a cause for the female bias is hard to envisage.
As only a fraction of human embryos survive implanta-
tion and fetal life (45), there is potential for improving sur-
vival. There are also sex diff  erences in the mechanisms by 
which embryos fail to survive and the timing of these events 
(46). For example, for embryos with normal karyotype, the 
rate of spontaneous abortion during early pregnancy is greater 
for females than males, so any combination of genetic factors 
that reduced the eff  ect would be specifi  cally overrepresented 
in the female population (46). Candidate mechanisms involve 
KIR–HLA interactions within the growing fetus, which 
could contribute to tissue development or defense against 
infection. NK cells are detectable in fetuses aborted at 6–24 wk 
of gestation, pointing to their possible contribution (47). Also 
of possible relevance, KIR3DL3 transcripts are more abun-
dant in the NK cells of females than males and, although the 
protein appears undetectable in adult cells, it may function 
during fetal development (48).
After birth, the favored KIR–HLA combinations could 
improve survival, relative to other combinations, through 
NK or T cell responses that eliminate infection or cancer, or 
prevent autoimmune disease. Female specifi  city could arise in 
a general way from the hormonal diff  erences between men 
and women, and their infl  uences on the immune system (49, 
50), or more specifi  cally to immune functions under circum-
stances experienced only by women, such as menstruation, 
pregnancy, nursing, cancer of breast, or ovary.
Precedent for KIR–HLA combinations infl  uencing hu-
man reproduction and survival is the work of Hiby et al. (15). 
They found that inhibitory combinations of fetal HLA-C2 
and maternal homozygosity for A KIR haplotypes predispose 
Caucasians to preeclampsia. These correlations fi  t well with 
the observed interactions of fetal trophoblast with maternal 
NK cells during placentation. Selection by preeclampsia can 
also explain the inverse correlation between C2 and A hap-
lotype frequencies in human populations, as exemplifi  ed by 
the low C2 and high group A frequencies in the Japanese. In 
this context, it is important to note that the correlations re-
ported here do not address the fi  tness of allogeneic combina-
tions of maternal and fetal factors, but of the KIR and HLA 
genes brought together in the child’s genotype. Conse-
quently, the biology underlying the overrepresented and un-
derrepresented KIR–HLA combinations we fi  nd may well be 
distinct from those described by Hiby et al. (15).
A signature of natural selection on KIR diversity
KIR-expressing NK cells participate in defense against infec-
tion and in reproduction, two functions that are essential for 
the survival of individuals, populations, and species. Both the 
KIR and their cognate HLA class I ligands are highly vari-
able. In comparison with Caucasians, the Japanese population 
has a skewed distribution of KIR and HLA variants, refl  ect-
ing a distinct history of directional and balancing selection. 
Functional and genetic study of a Japanese panel provides ev-
idence here that the combination of KIR and HLA variation 
acts to diversify NK cell repertoire and eff  ector  function 
within the population and to facilitate human survival.
MATERIALS AND METHODS
Human subjects and blood samples. Blood samples were from 132 
healthy, unrelated Japanese individuals (54 males and 78 females, ages 22–73, 
mean 40 ± 12 yr [SD]) and from related donors in three pedigrees; informed 
consent was as approved by the Stanford University Institutional Review 
Board on Human Subjects. PBMCs were prepared with Ficoll-Paque PLUS 
(GE Healthcare). Genomic DNA and RNA were extracted with DNAzol 
(Molecular Research Center) and TRIzol (Invitrogen). Complementary 
DNA was synthesized from RNA, using oligo(dT) and SMART II oligonu-
cleotide primers (SMART-RACE kit; CLONTECH Laboratories, Inc.).
KIR and HLA typing. KIR genes were typed as described previously 
(22). 5′RACE used the Advantage 2 PCR kit (CLONTECH Laboratories, JEM VOL. 203, March 20, 2006  643
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Inc.), with the universal primer (UPM) from the SMART-RACE kit or 
KIR-specifi  c primers as the forward primer combined with KIR-specifi  c 
reverse primers (Fig. S7, available at http://www.jem.org/cgi/content/full/
jem.20051884/DC1). KIR transcripts were cloned into the pGEM T-easy 
vector (Promega) and sequenced using BigDye terminator 3.1 chemistry and 
a PRISM 377 DNA sequencer (Applied Biosystems). Sequence assembly 
and analysis used AlignIR version 2.0 (LICOR). Three or more clones from 
two or more independent PCR reactions were sequenced to defi  ne novel 
polymorphisms. KIR allele typing by sequence-specifi  c polymorphism PCR 
used novel primers and those described previously (25, 34, 41, 51) (Figs. 
S8–S10, available at http://www.jem.org/cgi/content/full/jem.20051884/
DC1). PCR used hot-start procedures using AmpliTaq FS on a PE9600 
thermalcycler (Applied Biosystems). The juxtaposition of 2DL5,  2DS3, 
and 2DS5 to either 2DL2 or 3DS1 was determined by long-range PCR 
(52). Exon 1 was sequenced directly from the PCR products to distinguish 
2DL5*002 from *005. In exon 6 of 2DL4, the cluster of 9 or 10 adenines 
(9A/10A) were typed by sequencing (35). HLA-A, B, C typing was by se-
quencing locus-specifi  c PCR products (minimally exons 2 and 3, but also 
exon 4 for some samples) with adaptations from Dunn et al. (53) and PCR-
SSOP (Sequence-Specifi  c Oligonucleotide Probing), using LABType SSO 
Typing Tests (One Lambda).
Flow cytometry and NK cell secretion of IFN-𝗄. KIR on 
CD56+CD3−NK cell surfaces was measured with monoclonal antibodies 
and fl   ow cytometry (22). Phycoerythrin conjugates of anti-2DL1/2DS1 
(EB6; Beckman Coulter), anti-2DL2/2DL3/2DS2 (DX27), and anti-
3DL1(DX9) (BD Biosciences), anti-3DL2 (DX31, a gift from Drs. J. Phillips 
and L. Lanier, DNAX Research Institute, Palo Alto, CA) were used in 
  combination with anti-CD3–PerCP (SK7) and anti-CD56–fl  uorescein 
(NCAM16.2) (BD Biosciences) to stain PBMCs. Three-color fl  ow cytome-
try used a FACScan instrument and CELLQuest software (BD Biosciences). 
Parameters measured were the percent NK cells binding an antibody and the 
mean fl  uorescence intensity (mfi  ) for the positive cells.
PBMCs from donors heterozygous for high- and low-binding 3DL1 al-
lotypes were cocultured with the class I–defi  cient 721.221 cell line or 221 
transfected with HLA-B*5801. After gating on 3DL1+ NK cells, IFN-γ 
production was assessed by intracellular staining (54): PBMCs at 6 × 105 
cells/well were cocultured with target cells at an optimized eff  ector–target 
ratio of 1:1 for 9 h; fl  uorescent anti-CD3 and anti-CD85–PECy5 (GHI/75) 
(BD Biosciences) were added so that 3DL1+ T cells and the inhibitory ef-
fects of LIR1 could be excluded from analysis. Knowing the proportion of 
donor NK cells expressing each 3DL1 allotype, the inhibitory eff  ect on total 
NK cells was calculated for each allotype: (% IFN-γ inhibition) × (% allo-
type-expressing NK cells).
Statistical methods. Reconstruction of allele-level KIR haplotypes used 
the expectation maximization algorithm (Arlequin version 2.001;  <CIT>reference 
55 </CIT>) and a Bayesian statistical method using hidden Monte Carlo Markov 
Chain modeling (PHASE version 2.1;  <CIT>reference 56 </CIT>). LD was calculated for 
pairs of KIR alleles (Arlequin version 2.001), D′ values >0.5 with P < 0.002 
are shown in Fig. S5. The homozygosity statistic F of Ewens (30) and 
Watterson (31), calculated from KIR allele frequencies was compared with 
expected homozygosity statistics; signifi  cance levels were tested using Slatkin’s 
exact test (57) (Arlequin version 2.001). Tajima’s D (32) was calculated for 
7-kb haplotypes constructed by combining the coding sequences of KIR al-
leles on group A haplotypes in order. 10 potential recombination points be-
tween haplotypes were fi  rst detected by the four-gamete test (58). D values 
were then calculated in a 300-bp sliding window along the composite hap-
lotypes without extending over the recombination points, and visualized 
(DnaSP version 4.0;  <CIT>reference 59</CIT>). For the 9A KIR2DL4 alleles and the 
22-bp deletion 2DS4 alleles, each deleted nucleotide was considered an 
independent position. Haplotype homozygosity was calculated at each gene 
in group A haplotypes based on Sabeti et al.’s method (33).
Nonparametric tests of signifi  cance were used in the analyses described 
in Figs. 3, 4, 5 and Fig. S4 (two-tailed Mann-Whitney’s U-test). Chi-squared 
tests were used in 2 × 2 contingency tables for pairwise comparisons of ge-
netic associations in Fig. 7. P < 0.05 was considered statistically signifi  cant. 
Fisher’s exact test was applied when expected numbers were small (n < 5). 
Tests used SPSS version 8 software (SPSS Inc). Signifi  cance values are as fol-
lows: *, P < 0.05; **, P < 0.01; ***, P < 0.005; ****, P < 0.001; and 
*****, P < 0.0005.
Online supplemental material. Fig. S1 depicts comparison of KIR allele 
frequencies between Japanese and Caucasians. Fig. S2 shows kinetics of DX9 
binding and phenotype comparison with Z27. Fig. S3 A contains compari-
son of HLA class I allele distributions between Japanese and Caucasians. Fig. 
S3 B shows heterozygosity of HLA class I and KIR. Fig. S4 depicts the infl  u-
ence of cognate HLA class I on KIR expression. Fig. S5 displays LD between 
KIR alleles. Fig. S6 shows the frequency of centromeric and telomeric parts 
in 44 haplotypes. Fig. S7 contains primers and PCR conditions for KIR 
cDNA cloning. Fig. S8 depicts primers for KIR allele typing. Fig. S9 shows 
PCR conditions for KIR allele typing. Fig. S10 depicts primer combinations 
for KIR allele typing. Online supplemental fi  gures are available at http://
www.jem.org/cgi/content/full/jem.20051884/DC1.
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